Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Details

Database :

OAIster

Journal :

Oemrawsingh , R , Akkerhuis , M , Vark , L , Redekop , K , Rudez , G , Remme , WJ , Bertrand , ME , Fox , KM , Ferrari , R , Danser , J , de Maat , M , Simoons , M , Brugts , J & Boersma , E 2016 , ' Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model ' , Journal of the American Heart Association , vol. 5 , no. 3 , pp. e002688 .

Notes :

application/pdf, English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1313620052

Document Type :

Electronic Resource